**Core Concept**
Sulfonylureas, a class of anti-hyperglycemic drugs, lower blood glucose levels by stimulating insulin secretion from the pancreatic beta cells. This action can sometimes lead to an unintended consequence of hypoglycemia.

**Why the Correct Answer is Right**
The hypoglycemia caused by sulfonylureas is an example of a dose-dependent pharmacologic effect, which is an adverse drug reaction. This occurs when the drug's intended action (stimulating insulin secretion) exceeds the desired therapeutic effect, resulting in an undesirable outcome (hypoglycemia). The mechanism involves the binding of sulfonylureas to pancreatic beta cell ATP-sensitive potassium channels (K_ATP channels), leading to their closure and depolarization. This triggers the opening of voltage-gated calcium channels, causing an influx of calcium ions, which in turn stimulates the release of insulin.

**Why Each Wrong Option is Incorrect**
**Option A:** Type A hypersensitivity reaction - This is incorrect because sulfonylureas do not trigger an immune-mediated response.
**Option B:** Type B hypersensitivity reaction - This is incorrect because sulfonylureas do not involve an immune response or the formation of antibodies.
**Option C:** Idiosyncratic drug reaction - This is incorrect because hypoglycemia caused by sulfonylureas is a predictable dose-dependent effect rather than an unpredictable, idiosyncratic reaction.

**Clinical Pearl / High-Yield Fact**
It's essential for clinicians to be aware of the risk of hypoglycemia associated with sulfonylureas and to monitor patients closely, especially when initiating or adjusting therapy. This includes advising patients on the symptoms of hypoglycemia and providing guidance on managing episodes.

**Correct Answer: C. Idiosyncratic drug reactions are unpredictable and not dose-dependent, whereas the hypoglycemia caused by sulfonylureas is a predictable, dose-dependent effect.